Yibo Dai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yibo Dai has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Jianliu Wang
Peking University People’s Hospital
5 shared publications - Yangyang Dong
Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China
3 shared publications - Zhiqi Wang
Department of Obstetrics and Gynecology, Beijing Friendship Hospital, Capital Medical University
3 shared publications - Hongyi Hou
Department of Obstetrics and Gynecology
2 shared publications - Yuan Cheng
Department of Obstetrics and Gynecology, Peking University People’s Hospital, Beijing, China
2 shared publications - Cai-Hong Yun
Peking University Health Science Center
1 shared publication
Latest Publications
- Open Access
- 1 December 2025
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (12) , 8271-8284
Laparoscopic surgery is effective and safe in high-risk endometrial cancer
Background: Laparoscopy for early/low-risk endometrial cancer (EC) is safe, but evidence for high-risk cases is insufficient. This study aimed to compare perioperative safety and survival outcomes between high-risk EC patients receiving laparoscopic surgery and laparotomy. Methods: A total of 267 high-risk EC patients (stage IA, grade 3; stage IA, type II tumors; stage IB-III, regardless of histologic grade) undergone surgery in Peking University People’s Hospital from 2006 to 2016 were retrospectively enrolled in the study. To evaluate the safety of laparoscopic surgery, the incidence of perioperative complications and long-term oncological outcomes were compared between patients receiving laparoscopic surgery or laparotomy. Survival analysis was performed using the Kaplan-Meier method and Cox regression. Results: Laparoscopic approach was associated with shorter mean operative time (183.0±60.3 vs. 202.3±67.0 mins, P=0.02), less blood loss (210.2±255.5 vs. 484.9±328.2 mL, Pvs. 31.6%, Pvs. 84.6%, P=0.33) and overall survival (95.6% vs. 90.2%, P=0.58). In multivariate analysis, both stage and grade were associated with oncological outcomes whereas surgical approach was not a risk factor for prognosis. Conclusions: Laparoscopic surgery is effective and safe in high-risk EC, though further validations by randomized clinical trials are needed.
- 1 December 2025
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (12) , 8271-8284
Open AccessLaparoscopic surgery is effective and safe in high-risk endometrial cancer
Background: Laparoscopy for early/low-risk endometrial cancer (EC) is safe, but evidence for high-risk cases is insufficient. This study aimed to compare perioperative safety and survival outcomes between high-risk EC patients receiving laparoscopic surgery and laparotomy. Methods: A total of 267 high-risk EC patients (stage IA, grade 3; stage IA, type II tumors; stage IB-III, regardless of histologic grade) undergone surgery in Peking University People’s Hospital from 2006 to 2016 were retrospectively enrolled in the study. To evaluate the safety of laparoscopic surgery, the incidence of perioperative complications and long-term oncological outcomes were compared between patients receiving laparoscopic surgery or laparotomy. Survival analysis was performed using the Kaplan-Meier method and Cox regression. Results: Laparoscopic approach was associated with shorter mean operative time (183.0±60.3 vs. 202.3±67.0 mins, P=0.02), less blood loss (210.2±255.5 vs. 484.9±328.2 mL, Pvs. 31.6%, Pvs. 84.6%, P=0.33) and overall survival (95.6% vs. 90.2%, P=0.58). In multivariate analysis, both stage and grade were associated with oncological outcomes whereas surgical approach was not a risk factor for prognosis. Conclusions: Laparoscopic surgery is effective and safe in high-risk EC, though further validations by randomized clinical trials are needed.
- Open Access
- 16 April 2021
- Published by Wiley in Journal of Oncology
- Vol. 2021, 1-8
Sentinel Lymph Node Biopsy Is Feasible in Cervical Cancer Laparoscopic Surgery: A Single-Center Retrospective Cohort Study
Background and Objective. Sentinel lymph node (SLN) biopsy efficiency has been confirmed in various solid tumors. This study aimed to assess SLN biopsy feasibility in clinical application and explore how to improve its detection rates and diagnostic accuracy in cervical cancer laparoscopic surgery. Methods. A total of 100 cervical cancer patients undergoing laparoscopic surgery with SLN biopsy were included. Indocyanine green, carbon nanoparticles (CNPs), and a combination of both were used during surgeries. Detection rates, sensitivity, negative predictive value (NPV) of SLN biopsy, and related factors were analyzed. Results. The overall and bilateral SLN detection rates were 92% (92/100) and 74% (74/100), respectively. Combined tracers had higher bilateral SLN detection rates than CNPs alone ( ). Menopause and lymph node metastasis were associated with lower overall and bilateral SLN detection rates ( ). SLN biopsy sensitivity and NPV for lymph node metastasis in patients with at least one detected SLN were 81.8% (9/11) and 97.3% (72/74), respectively. Among those with bilateral detected SLNs, higher sensitivity and NPV of 87.5% (7/8) and 98.3% (57/58) were observed, respectively. SLN algorithm can ensure that all patients with lymph node metastasis are detected by SLN biopsy. Conclusion. SLN biopsy appears to be safe and effective for specific cervical cancer patients with high detection rates and NPV in laparoscopic surgery, especially for those with detected bilateral SLNs and undergoing the SLN algorithm. Selecting suitable patients for SLN mapping has prospects for clinical application.
- 16 April 2021
- Published by Wiley in Journal of Oncology
- Vol. 2021, 1-8
Open AccessSentinel Lymph Node Biopsy Is Feasible in Cervical Cancer Laparoscopic Surgery: A Single-Center Retrospective Cohort Study
Background and Objective. Sentinel lymph node (SLN) biopsy efficiency has been confirmed in various solid tumors. This study aimed to assess SLN biopsy feasibility in clinical application and explore how to improve its detection rates and diagnostic accuracy in cervical cancer laparoscopic surgery. Methods. A total of 100 cervical cancer patients undergoing laparoscopic surgery with SLN biopsy were included. Indocyanine green, carbon nanoparticles (CNPs), and a combination of both were used during surgeries. Detection rates, sensitivity, negative predictive value (NPV) of SLN biopsy, and related factors were analyzed. Results. The overall and bilateral SLN detection rates were 92% (92/100) and 74% (74/100), respectively. Combined tracers had higher bilateral SLN detection rates than CNPs alone ( ). Menopause and lymph node metastasis were associated with lower overall and bilateral SLN detection rates ( ). SLN biopsy sensitivity and NPV for lymph node metastasis in patients with at least one detected SLN were 81.8% (9/11) and 97.3% (72/74), respectively. Among those with bilateral detected SLNs, higher sensitivity and NPV of 87.5% (7/8) and 98.3% (57/58) were observed, respectively. SLN algorithm can ensure that all patients with lymph node metastasis are detected by SLN biopsy. Conclusion. SLN biopsy appears to be safe and effective for specific cervical cancer patients with high detection rates and NPV in laparoscopic surgery, especially for those with detected bilateral SLNs and undergoing the SLN algorithm. Selecting suitable patients for SLN mapping has prospects for clinical application.
- Open Access
- 1 January 2021
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 32 (3) , e30
Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer
Cheng Y, et al. J Gynecol Oncol. 2021 Jan;32(3):e30. https://doi.org/10.3802/jgo.2021.32.e30
- 1 January 2021
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 32 (3) , e30
Open AccessIdentification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer
Cheng Y, et al. J Gynecol Oncol. 2021 Jan;32(3):e30. https://doi.org/10.3802/jgo.2021.32.e30
- 1 July 2020
- Published by Elsevier in Gynecologic Oncology
- Vol. 158 (1) , 92-98
Survival of microsatellite-stable endometrioid endometrial cancer patients after minimally invasive surgery: An analysis of the Cancer Genome Atlas data
- 1 July 2020
- Published by Elsevier in Gynecologic Oncology
- Vol. 158 (1) , 92-98
Survival of microsatellite-stable endometrioid endometrial cancer patients after minimally invasive surgery: An analysis of the Cancer Genome Atlas data
- Open Access
- 1 January 2020
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 31 (3) , e27
Prognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center
Dai Y, et al. J Gynecol Oncol. 2019 Jun;31:e27. https://doi.org/10.3802/jgo.2020.31.e27
- 1 January 2020
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 31 (3) , e27
Open AccessPrognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center
Dai Y, et al. J Gynecol Oncol. 2019 Jun;31:e27. https://doi.org/10.3802/jgo.2020.31.e27
- 16 June 2017
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 60 (13) , 5927-5932
Structure Based Design of N-(3-((1H-Pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides as Selective Leucine-Zipper and Sterile-α Motif Kinase (ZAK) Inhibitors
A series of N-(3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides were designed as the first class of highly selective ZAK inhibitors. The representative compound 3h strongly inhibits the kinase activity of ZAK with an IC50 of 3.3 nM and dose-dependently suppresses the activation of ZAK downstream signals in vitro and in vivo, while it is significantly less potent for the majority of 403 nonmutated kinases evaluated. Compound 3h also exhibits orally therapeutic effects on cardiac hypertrophy in a spontaneous hypertensive rat model.
- 16 June 2017
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 60 (13) , 5927-5932
Structure Based Design of N-(3-((1H-Pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides as Selective Leucine-Zipper and Sterile-α Motif Kinase (ZAK) Inhibitors
A series of N-(3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides were designed as the first class of highly selective ZAK inhibitors. The representative compound 3h strongly inhibits the kinase activity of ZAK with an IC50 of 3.3 nM and dose-dependently suppresses the activation of ZAK downstream signals in vitro and in vivo, while it is significantly less potent for the majority of 403 nonmutated kinases evaluated. Compound 3h also exhibits orally therapeutic effects on cardiac hypertrophy in a spontaneous hypertensive rat model.